Trials / Not Yet Recruiting
Not Yet RecruitingNCT05598359
TA-65 and Aging Associated Microvascular Dysfunction
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 180 (estimated)
- Sponsor
- Medical College of Wisconsin · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
The goal of this clinical trial is to test whether activation of telomerase with a dietary supplement (TA-65) improves microvascular function.
Detailed description
The purpose of this clinical trial is to examine whether activation of autophagy with TA-65 which activates telomerase, improves microvascular function and blood pressure in an older population
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | TA-65 | TA-65 is a purified small molecule extracted from Astragalus root |
| OTHER | Placebo | Inactive formulation |
Timeline
- Start date
- 2026-01-01
- Primary completion
- 2028-12-31
- Completion
- 2029-12-31
- First posted
- 2022-10-28
- Last updated
- 2025-04-28
Source: ClinicalTrials.gov record NCT05598359. Inclusion in this directory is not an endorsement.